Apeiron Investment Group Ltd. 13D/13G Filings for

Apeiron Investment Group Ltd. 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-12-30
4:31 pm
Purchase
2021-12-20 13D Neuphoria Therapeutics Inc.
NEUP
Apeiron Investment Group Ltd. 33,545,866
27.700%
33,545,866increase
(New Position)
Filing